These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18598919)

  • 1. Present perspectives on flaviviral chemotherapy.
    Ghosh D; Basu A
    Drug Discov Today; 2008 Jul; 13(13-14):619-24. PubMed ID: 18598919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rodent models for the study of therapy against flavivirus infections.
    Charlier N; Leyssen P; De Clercq E; Neyts J
    Antiviral Res; 2004 Aug; 63(2):67-77. PubMed ID: 15321702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.
    Pastorino B; Nougairède A; Wurtz N; Gould E; de Lamballerie X
    Antiviral Res; 2010 Sep; 87(3):281-94. PubMed ID: 20452379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse and hamster models for the study of therapy against flavivirus infections.
    Charlier N; De Clercq E; Neyts J
    Novartis Found Symp; 2006; 277():218-29; discussion 229-32, 251-3. PubMed ID: 17319165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel model for the study of the therapy of flavivirus infections using the Modoc virus.
    Leyssen P; Van Lommel A ; Drosten C; Schmitz H; De Clercq E ; Neyts J
    Virology; 2001 Jan; 279(1):27-37. PubMed ID: 11145886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding new medicines for flaviviral targets.
    Keller TH; Chen YL; Knox JE; Lim SP; Ma NL; Patel SJ; Sampath A; Wang QY; Yin Z; Vasudevan SG
    Novartis Found Symp; 2006; 277():102-14; discussion 114-9, 251-3. PubMed ID: 17319157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinvasive flavivirus infections.
    Sips GJ; Wilschut J; Smit JM
    Rev Med Virol; 2012 Mar; 22(2):69-87. PubMed ID: 22086854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in flavivirus drug discovery.
    Kok WM
    Expert Opin Drug Discov; 2016; 11(5):433-45. PubMed ID: 26966889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusogenic peptide as diagnostic marker for detection of flaviviruses.
    Pattnaik P; Srivastava A; Abhyankar A; Dash PK; Parida MM; Lakshmana Rao PV
    J Postgrad Med; 2006; 52(3):174-8. PubMed ID: 16855316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis.
    Chong HY; Leow CY; Abdul Majeed AB; Leow CH
    Virus Res; 2019 Dec; 274():197770. PubMed ID: 31626874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targets for flavivirus drug discovery.
    Sampath A; Padmanabhan R
    Antiviral Res; 2009 Jan; 81(1):6-15. PubMed ID: 18796313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel antivirals against flaviviruses.
    Patkar CG; Kuhn RJ
    Novartis Found Symp; 2006; 277():41-52; discussion 52-6, 71-3, 251-3. PubMed ID: 17319153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of viral and cellular factors on flavivirus entry.
    Cordero-Rivera CD; De Jesús-González LA; Osuna-Ramos JF; Palacios-Rápalo SN; Farfan-Morales CN; Reyes-Ruiz JM; Del Ángel RM
    Curr Opin Virol; 2021 Aug; 49():164-175. PubMed ID: 34171540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Alkhurma virus (family Flaviviridae, genus Flavivirus): an emerging pathogen responsible for hemorrhage fever in the Middle East].
    Charrel RN; de Lamballerie X
    Med Trop (Mars); 2003; 63(3):296-9. PubMed ID: 14579470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Phytochemical Compounds as Antiviral Agents Against Arboviruses from the Genera Flavivirus and Alphavirus.
    Sardari S; Rafieian-Kopaei M; Malekmohammad K; Sewell RDE
    Curr Drug Discov Technol; 2020; 17(4):484-497. PubMed ID: 31969106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New approaches to the treatment of the flavivirus infections].
    Morozova OV; Isaeva EI; Viazov SO
    Vopr Virusol; 2015; 60(6):5-9. PubMed ID: 27024909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.
    Eyer L; Nencka R; de Clercq E; Seley-Radtke K; Růžek D
    Antivir Chem Chemother; 2018; 26():2040206618761299. PubMed ID: 29534608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The flavivirus capsid protein: Structure, function and perspectives towards drug design.
    Oliveira ERA; Mohana-Borges R; de Alencastro RB; Horta BAC
    Virus Res; 2017 Jan; 227():115-123. PubMed ID: 27751882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of highly pathogenic RNA viral infections: encephalitis viruses.
    Holbrook MR; Gowen BB
    Antiviral Res; 2008 Apr; 78(1):69-78. PubMed ID: 18031836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses.
    Lee E; Pavy M; Young N; Freeman C; Lobigs M
    Antiviral Res; 2006 Jan; 69(1):31-8. PubMed ID: 16309754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.